Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

Allergy(2022)10.1111/all.15544Source: DataRank Database

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes is a research paper published in Allergy (2022). On theSindex it has a DataRank of 0. It has been cited 161 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access161 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 19.63)OA: hybridTopics (59)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Amy D. Klion ORCID,Florence Roufosse ORCID,Dagmar Simon ORCID,Georgia Metzgeroth,Kristin M. Leiferman ORCID

Live enrichment

PubMed:36207764 PMC:PMC9797433 OpenAlex:https://openalex.org/W4303579270

NIAID NIH HHS

Grant: U19 AI136443

Swiss National Science Foundation

Grant: 310030

Intramural NIH HHS

Grant: ZIA AI001130

NIAID NIH HHS

Grant: R21 AI159586

Swiss National Science Foundation

Grant: 184816

National Institutes of Health

Grant: 5R21AI159586-02

Exploiting Siglec-6 for targeted anti-allergy drug delivery into human mast cells

National Institutes of Health

Grant: 1U19AI136443-01

Using siglecs and their ligands to treat allergic diseases SALTAD

FWCI

19.63

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.15544

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.15544

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15544

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/all.15544

journalhttps://doi.org/10.1111/all.15544

Fields of Study

Eosinophilic Disorders and SyndromesEosinophilic EsophagitisInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis0301 basic medicine03 medical and health sciences0302 clinical medicineHumansEosinophilsEosinophiliaSyndromeHypersensitivityHypereosinophilic Syndrome

MeSH Terms

EosinophiliaEosinophilsHumansHypersensitivitySyndromeHypereosinophilic Syndrome

Keywords

EosinophilMedicineImmunologyAsthmaClassificationDiagnostic criteriaPersonalized MedicineHypereosinophilic SyndromeEosinophilic LeukemiaEosinophilia DiagnosisAllergyEosinophils PathologyFEATURESVARIANTIMATINIB MESYLATEHypereosinophilic Syndrom ComplicationsEosinophiliaEosinophiliad EtiologyHypersensitivityHumansINTERLEUKIN-5Hypersensitivity -- complicationsReview ArticlesHypersensitivity ComplicationsHypereosinophilic Syndrome EtiologyScience & TechnologyRECEPTORCYTOKINESEosinophilia -- diagnosis -- etiology -- drug therapyMédecine pathologie humaineSyndromeEosinophils -- pathology3204 ImmunologyEosinophils1107 ImmunologyDISEASESEosinophilia Drug TherapyHEALTHHypereosinophilic Syndrome -- etiology -- complicationsLife Sciences & BiomedicineRESPONSES

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being